1932

Abstract

Studies of B cell lymphomas in the early 1980s led to the cloning of genes ( and ) at a chromosome translocation breakpoint. A rush followed to identify recurrently translocated genes in all types of cancer, which led to remarkable advances in our understanding of cancer genetics. B lymphocyte tumors commonly bear chromosome translocations to immunoglobulin genes, which points to a role for antibody gene diversification processes in tumorigenesis. The discovery of activation-induced cytidine deaminase (AID) and the use of murine models to study translocation have led to a new understanding of how these events contribute to the genesis of lymphomas. Here, we review these advances with a focus on AID and insights gained from the study of translocations in primary cells.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-pathol-020712-164004
2013-01-24
2024-04-17
Loading full text...

Full text loading...

/content/journals/10.1146/annurev-pathol-020712-164004
Loading
/content/journals/10.1146/annurev-pathol-020712-164004
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error